Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 40 most recent Form 4 transactions.
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 44,982 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,074 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 29,073 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 84,051 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 141,205 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 70,279 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 2,328 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 5,032 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 3,421 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 47,573 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 20,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 20,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 20,000 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 152,616 | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 26, 2025 | AKRO | Akero Therapeutics, Inc. | GGIFT | 9,259 | — | — | -4.4% | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 4,739 | — | — | — | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 3,527 | — | — | — | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 4,284 | — | — | — | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 4,739 | $21.10 | $100K | +2.3% | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 3,527 | $28.35 | $100K | +1.8% | Open the original filing on SEC.gov |
| Nov 24, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 4,284 | $21.09 | $90.3K | +2.2% | Open the original filing on SEC.gov |
| Oct 1, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Oct 1, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 4,201 | $47.98 | $201.6K | -2.1% | Open the original filing on SEC.gov |
| Oct 1, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 8,299 | $47.64 | $395.4K | -4.0% | Open the original filing on SEC.gov |
| Oct 1, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $21.10 | $263.8K | +6.3% | Open the original filing on SEC.gov |
| Sep 11, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 586 | $43.02 | $25.2K | -0.3% | Open the original filing on SEC.gov |
| Sep 2, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Sep 2, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 61 | $47.58 | $2.9K | <0.1% | Open the original filing on SEC.gov |
| Sep 2, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 2,739 | $47.14 | $129.1K | -1.4% | Open the original filing on SEC.gov |
| Sep 2, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 9,700 | $45.78 | $444K | -4.6% | Open the original filing on SEC.gov |
| Sep 2, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $21.10 | $263.8K | +6.3% | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 1,349 | $48.32 | $65.2K | -0.7% | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL◷ | 11,151 | $47.72 | $532.1K | -5.3% | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◷ | 12,500 | $21.10 | $263.8K | +6.3% | Open the original filing on SEC.gov |
| Jun 30, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 890 | $23.87 | $21.2K | +0.4% | Open the original filing on SEC.gov |
| Jun 18, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 1,453 | $54.84 | $79.7K | -0.7% | Open the original filing on SEC.gov |
| Jun 10, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 2,493 | $53.99 | $134.6K | -1.2% | Open the original filing on SEC.gov |